Nocion Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15 Main St PMB 247, Watertown, Massachus...Phone Number
(781) 819-2877Website
www.nociontx.comRevenue
<$5 MillionIndustry
About Nocion Therapeutics
Nocion Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of conditions related to neurogenic inflammation. They develop a novel therapy called nocions, which selectively target activated nociceptors to provide sustained relief for serious conditions including cough, itch, pain, and inflammation. Their approach involves the use of small molecules that inhibit sodium channels in inflamed sensory neurons, offering significant advantages over traditional treatments. Nocion aims to address various medical needs across multiple indications, including pulmonology, gynecology, pain management, dermatology, gastroenterology, and ophthalmology.Explore more
SIC Code 28,283NAICS Code 32,325Show moreNocion Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Compare Similar Companies to Nocion Therapeutics
Compare insights from companies similar to Nocion Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nocion Therapeutics Tech Stack
A closer look at the technologies used by Nocion Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nocion Therapeutics
Sign Up For FreeTo access detailed company insights
Nocion Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of conditions related to neurogenic inflammation. They develop a novel therapy called nocions, which selectively target activated nociceptors to provide sustained relief for serious conditions including cough, itch, pain, and inflammation. Their approach inv... Read More
